Last reviewed: June 27, 2026

Last updated: June 27, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

When people ask about the other weight loss drug like Ozempic, they're usually referring to tirzepatide, which FDA-approved Mounjaro in 2023. Unlike semaglutide, which mimics one hormone called GLP-1, tirzepatide activates both GLP-1 and GIP receptors in the brain and pancreas. Clinical trials show tirzepatide produces greater average weight loss than semaglutide alone, though individual results vary based on genetics and metabolism.

How Tirzepatide Differs From Semaglutide

Semaglutide and tirzepatide work through different mechanisms despite both being injectable peptides. Semaglutide is a GLP-1 receptor agonist, meaning it activates one specific pathway in your brain that controls hunger and blood sugar. Tirzepatide is a GIP/GLP-1 receptor agonist, activating two pathways simultaneously. This dual action means tirzepatide affects both appetite suppression and metabolic rate differently than semaglutide.

In the SURPASS-2 clinical trial, tirzepatide demonstrated mean weight loss of 22.5% at the highest dose, compared to 16.0% for semaglutide at its highest dose over 68 weeks. The difference becomes more pronounced as doses increase, suggesting tirzepatide's dual-hormone approach may offer additional benefits for moderate to severe obesity. Both medications slow gastric emptying, but tirzepatide's GIP component may enhance fat burning and energy expenditure.

Which Patients Respond Better to Each Medication

Response to semaglutide and tirzepatide varies based on individual genetic factors controlling peptide sensitivity. Some patients carry genetic variants that enhance their GLP-1 receptor responsiveness, making semaglutide highly effective for them. Others have stronger genetic predisposition toward GIP pathway activation, where tirzepatide may produce superior results. PlexusDx's Precision Peptide Genetic Test analyzes key variants including GLP1R rs6923761 and GIPR rs1800437 to identify which pathway dominates your peptide sensitivity profile.

Age, baseline weight, and metabolic health also influence medication selection. Patients with type 2 diabetes often benefit from semaglutide's established insulin-sensitizing effects, while those seeking maximum weight loss for obesity alone may achieve better outcomes with tirzepatide. Neither medication is universally superior—the optimal choice depends on your specific genetic, metabolic, and health status.

Cost Comparison and Access at PlexusDx

Compounded semaglutide injection from PlexusDx starts at $149 per month, making it the most affordable GLP-1 option available. Compounded tirzepatide injection begins at $249 per month. Both medications come from licensed 503A compounding pharmacies and are available in all 50 states without insurance requirements or membership fees. PlexusDx accepts HSA and FSA payments, reducing out-of-pocket costs for eligible patients.

Your dose may need to go up as your body adjusts and your tolerance increases. Your price won't—PlexusDx maintains flat monthly pricing regardless of dose level. This transparent pricing model eliminates surprise increases as your treatment plan progresses. For patients seeking both semaglutide and tirzepatide benefits, PlexusDx offers GLP-Squared Injection (dual compound) starting at $249 per month.

Side Effects and Tolerability Differences

Both semaglutide and tirzepatide cause similar gastrointestinal side effects during the initial phase, including nausea, vomiting, and constipation that typically diminish within weeks. Tirzepatide may produce slightly more intense nausea during dose escalation due to its dual-receptor activation, though this varies widely between individuals. Semaglutide generally allows faster dose titration for patients sensitive to GI upset, making it preferable for those with prior medication intolerance.

Serious adverse events are rare with both medications when prescribed appropriately. Pancreatitis risk, thyroid concerns, and gallbladder issues require monitoring with both agents. PlexusDx patients receive ongoing clinical support and dose adjustments based on tolerance and efficacy. Genetic testing through the Precision Peptide Genetic Test may help predict which medication produces fewer unwanted effects for your individual pathways, though side effect severity remains unpredictable at the population level.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Is tirzepatide stronger than semaglutide for weight loss?

Tirzepatide produces greater average weight loss in clinical trials, but 'stronger' depends on your individual genetics and metabolism. Some patients respond better to semaglutide's single-pathway mechanism. PlexusDx recommends starting with your body's optimal medication based on genetic predisposition testing, then adjusting based on real-world response.

Can I switch from semaglutide to tirzepatide if results plateau?

Yes, many patients successfully transition between medications. Your PlexusDx provider can evaluate your progress and recommend switching if your weight loss plateaus or side effects become limiting. The transition typically takes 1-2 weeks and may boost results for patients whose genetic profile favors dual GIP/GLP-1 activation.

Why is compounded semaglutide cheaper than tirzepatide at PlexusDx?

Semaglutide has been in use longer and compounding economics reflect market maturity. PlexusDx's compounded semaglutide injection starts at $149/month while tirzepatide starts at $249/month—both from licensed 503A pharmacies. Pricing remains flat regardless of dose, so affordability improves as you optimize your medication choice.

Which medication causes fewer side effects?

Neither medication is universally better tolerated; individual responses depend on genetics and GI sensitivity. Some patients tolerate tirzepatide well while others prefer semaglutide's gentler initiation. PlexusDx's Precision Peptide Genetic Test identifies your peptide pathway strength, helping predict which medication aligns best with your physiology before starting treatment.

Does PlexusDx genetic testing predict which medication works better?

PlexusDx's Precision Peptide Genetic Test ($99 add-on after first month) analyzes 14 pathways and 150+ genetic insights, including GLP1R rs6923761 and GIPR rs1800437 variants. These results help your provider understand your peptide sensitivity pattern and may guide semaglutide versus tirzepatide selection, though clinical response always requires real-world monitoring and dose adjustment.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves